Spyre Therapeutics, Inc.

Report date

3/31/2022

Quarter

2022 Q1

Filed

5/16/2022

17,202

Value ($000)

Weight

0.0%

2019 Q4 - 2022 Q1 (10 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q1	5/16/2022	40	0.0%	17,202	3/31/2022
2021 Q4	2/15/2022	101	0.0%	21,314	12/31/2021
2021 Q3	11/15/2021	172	0.0%	21,698	9/30/2021
2021 Q2	8/16/2021	389	0.0%	55,861	6/30/2021
2021 Q1	5/18/2021	541	0.0%	68,275	3/31/2021
2020 Q4	2/16/2021	537	0.0%	68,275	12/31/2020
2020 Q3	11/17/2020	449	0.0%	63,313	9/30/2020
2020 Q2	8/17/2020	586	0.0%	63,313	6/30/2020
2020 Q1	5/13/2020	190	0.0%	40,749	3/31/2020
2019 Q4	2/14/2020	308	0.0%	40,283	12/31/2019